| Dore Ellen Kottler, RPH | |
|
3070 W Tilghman St, Allentown, PA 18104-4208 | |
| (610) 351-2091 | |
| Not Available |
| Full Name | Dore Ellen Kottler |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 3070 W Tilghman St, Allentown, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396347662 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | RP037497R (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dore Ellen Kottler, RPH 3070 W Tilghman St, Allentown, PA 18104-4208 Ph: (610) 351-2091 | Dore Ellen Kottler, RPH 3070 W Tilghman St, Allentown, PA 18104-4208 Ph: (610) 351-2091 |
News Archive
Higher levels of the omega-3 fatty acid eicosapentaenoic acid (EPA) found in the blood—and not a decrease in triglyceride levels as originally thought—appear to explain the striking reductions in cardiovascular events and deaths seen among people taking 4 grams daily of the prescription fish oil, icosapent ethyl, according to findings from a REDUCE-IT substudy presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology
Pfizer Inc. today announced that its board of directors authorized a new share repurchase program of up to $5 billion of its common stock. This is in addition to approximately $4 billion of authorization remaining under its current repurchase program and increases the company's total repurchase authorization to $9 billion.
PredictAD is an EU-funded research project that develops objective and efficient methods for enabling earlier diagnosis of Alzheimer's disease. Diagnosis requires a holistic view of the patient combining information from several sources, such as, clinical tests, imaging and blood samples.
Infusion of a combination therapy consisting of glucose, insulin, and potassium, which was thought could be a beneficial treatment immediately following a heart attack, may increase the risk of heart failure and death in the first 3 days for patients with ST-segment elevation myocardial infarction (STEMI; a certain pattern on an electrocardiogram following a heart attack), according to a study in the November 28 issue of JAMA: The Journal of the American Medical Association.
Boston University School of Medicine (BUSM) is the lead institution on a $13.6 million study aimed at developing novel technologies for the early detection of lung cancer.
› Verified 6 days ago
Jacinta M Hudak, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1855 S 5th St, Allentown, PA 18103 Phone: 610-791-7796 | |
Mr. Michael Francis Mastroianni, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5829 Tilghman St, Allentown, PA 18104 Phone: 610-398-3228 Fax: 610-530-1815 | |
Bhavini Patel Miller, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 361 S Cedar Crest Blvd, Allentown, PA 18103 Phone: 610-821-7999 Fax: 610-821-8191 | |
Umesh Patel, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1579 Kaitlyn Rd, Allentown, PA 18103 Phone: 484-221-9650 | |
Elizabeth Shober, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1200 S Cedar Crest Blvd, Allentown, PA 18103 Phone: 610-402-8887 | |
Mrs. Tammy Ann Hill, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6520 Stonegate Dr, Suite 100, Allentown, PA 18106 Phone: 610-794-5380 Fax: 610-794-5415 | |
Nicole Yeager, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 912 Airport Center Dr, Allentown, PA 18109 Phone: 610-573-5711 Fax: 610-573-5711 |